» Articles » PMID: 28521839

Associations Between Systemic Bone Mineral Density and Early Knee Cartilage Changes in Middle-aged Adults Without Clinical Knee Disease: a Prospective Cohort Study

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2017 May 20
PMID 28521839
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoarthritis has a high prevalence in people with high bone mineral density (BMD). Nevertheless, whether high systemic BMD predates early structural features of knee osteoarthritis is unclear. This study examined the association between systemic BMD and knee cartilage defect progression and cartilage volume loss in middle-aged people without clinical knee disease.

Methods: Adults (n = 153) aged 25-60 years had total body, lumbar spine, and total hip BMD assessed by dual-energy X-ray absorptiometry at baseline (2005-2008), and tibial cartilage volume and tibiofemoral cartilage defects assessed by magnetic resonance imaging at baseline and follow up (2008-2010).

Results: Higher spine BMD was associated with increased risk for progression of medial (OR = 1.45, 95% CI 1.10, 1.91) and lateral (OR = 1.30, 95% CI 1.00, 1.67) tibiofemoral cartilage defects. Total hip BMD was also positively associated with the progression of medial (OR = 1.63, 95% CI 1.10, 2.41) and lateral (OR = 1.53, 95% CI 1.08, 2.18) tibiofemoral cartilage defects. Greater total body, spine, and total hip BMD were associated with increased rate of lateral tibial cartilage volume loss (for every 1 g/10 cm increase in total body BMD: B = 0.44%, 95% CI 0.17%, 0.71%; spine BMD: 0.17%, 95% CI 0.04%, 0.30%; total hip BMD: 0.29%, 95% CI 0.13%, 0.45%), with no significant associations for medial tibial cartilage volume loss.

Conclusion: In middle-aged people without clinical knee disease, higher systemic BMD was associated with increased early knee cartilage damage. Further work is needed to clarify the effect of systemic BMD at different stages of the pathway from health through to disease in knee osteoarthritis, as new therapies targeting bone are developed for the management of knee osteoarthritis.

Citing Articles

Weaker subchondral bone and thinner articular cartilage of the knee are associated with elevated baseline fracture risk independently of osteoarthritis risk factors.

Wong A, Pokhoy A, Naraghi A, Mohankumar R Arch Osteoporos. 2025; 20(1):36.

PMID: 40055244 DOI: 10.1007/s11657-025-01517-4.


RANKL-mediated osteoclastic subchondral bone loss at a very early stage precedes subsequent cartilage degeneration and uncoupled bone remodeling in a mouse knee osteoarthritis model.

Hashimoto T, Akagi M, Tsukamoto I, Hashimoto K, Morishita T, Ito T J Orthop Surg Res. 2025; 20(1):226.

PMID: 40025588 PMC: 11874437. DOI: 10.1186/s13018-025-05578-6.


Causal association between bone mineral density and the risk of joint replacement in patients with osteoarthritis: a Mendelian randomization study.

Zhu R, Xing X, Bian J, Zhang X, Ge L, Cai G Clin Rheumatol. 2024; 44(2):823-830.

PMID: 39738847 DOI: 10.1007/s10067-024-07289-5.


Association between Low Serum Creatinine Levels and Knee Osteoarthritis in Koreans without Renal Insufficiency.

Lim C, Ryu D, Suh Y Yonsei Med J. 2024; 65(9):519-526.

PMID: 39193760 PMC: 11359604. DOI: 10.3349/ymj.2023.0456.


The Role of MicroRNAs in the Pathophysiology of Osteoarthritis.

Szala D, Kopanska M, Trojniak J, Jablonski J, Hanf-Osetek D, Snela S Int J Mol Sci. 2024; 25(12).

PMID: 38928059 PMC: 11204066. DOI: 10.3390/ijms25126352.


References
1.
Berry P, Wluka A, Davies-Tuck M, Wang Y, Strauss B, Dixon J . Sex differences in the relationship between bone mineral density and tibial cartilage volume. Rheumatology (Oxford). 2010; 50(3):563-8. DOI: 10.1093/rheumatology/keq341. View

2.
Drinka P, DeSmet A, Bauwens S, Rogot A . The effect of overlying calcification on lumbar bone densitometry. Calcif Tissue Int. 1992; 50(6):507-10. DOI: 10.1007/BF00582163. View

3.
Dequeker J, Aerssens J, Luyten F . Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res. 2004; 15(5):426-39. DOI: 10.1007/BF03327364. View

4.
Wildi L, Martel-Pelletier J, Abram F, Moser T, Raynauld J, Pelletier J . Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons. Arthritis Care Res (Hoboken). 2012; 65(5):686-94. DOI: 10.1002/acr.21890. View

5.
Radin E, Rose R . Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res. 1986; (213):34-40. View